Finance

Lists
Why is 600566 down 2.44%?
Dive Deeper
600566:SHA
Hubei Jumpcan Pharmaceutical Co Ltd
CN¥25.98
-2.44%
(-0.65) 1D
Oct 16, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600566...
Open
CN¥26.66
High
CN¥26.90
Low
CN¥25.74
Mkt. cap
23.95B
Avg. vol.
5.46M
Volume
7.22M
Dividend
6.70%
Quarterly dividend
CN¥0.44
Ex-dividend date
Jun 30, 2026
P/E ratio
13.03
52-wk high
CN¥29.60
52-wk low
CN¥21.13
EPS
CN¥1.99
Shares outstanding
814.34M
No. of employees
4K
Open
CN¥26.66
High
CN¥26.90
Low
CN¥25.74
Mkt. cap
23.95B
Avg. vol.
5.46M
Volume
7.22M
Dividend
6.70%
Quarterly dividend
CN¥0.44
Ex-dividend date
Jun 30, 2026
P/E ratio
13.03
52-wk high
CN¥29.60
52-wk low
CN¥21.13
EPS
CN¥1.99
Shares outstanding
814.34M
No. of employees
4K
News stories
From web sources and news partners
About Hubei Jumpcan Pharmaceutical Co Ltd
CEO-
Employees4.14K
FoundedJan 22, 1997
Headquarters-
SectorPharmaceutical industry
Websitejumpcan.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.18B
2.29B
1.21B
1.12B
Cost of goods sold
263.02M
376.60M
215.85M
264.37M
Cost of revenue
263.02M
376.60M
215.85M
264.37M
Research and development expenses
81.96M
113.25M
106.83M
102.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
475.98M
896.39M
531.31M
443.94M
Operating expense
565.64M
1.08B
604.29M
572.41M
Total operating expenses
828.66M
1.46B
820.14M
836.79M
Operating income
354.67M
827.18M
387.36M
284.03M
Other non operating income
4.98M
-5.35M
954.02K
-1.32M
EBT including unusual items
411.36M
901.85M
474.17M
457.68M
EBT excluding unusual items
383.78M
855.04M
454.87M
453.73M
Income tax expense
112.53M
147.70M
75.10M
74.73M
Effective tax rate
27.36%
16.38%
15.84%
16.33%
Other operating expenses
9.51M
45.61M
13.38M
22.69M
Net income
298.10M
755.39M
400.14M
384.08M
Net profit margin
25.19%
33.04%
33.14%
34.27%
Earnings per share
-
-
-
-
Interest and investment income
26.48M
35.26M
72.73M
178.07M
Interest expense
-2.35M
-2.04M
-6.17M
-7.03M
Net interest expenses
24.12M
33.23M
66.56M
171.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
429.95M
901.97M
462.15M
361.71M
Gain or loss from assets sale
68.41K
-173.23K
-
-22.04K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps